New data showing sustained complete renal response with LUPKYNIS through three years Monthly kidney function assessment no longer required after first year of treatment Safety profile remains unchanged and is… Read More
KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces it has entered into a warrant exercise agreement with an existing… Read More
Deciding to have an abortion is a deeply personal choice, and so is what comes next: determining the type of abortion that’s best for you. Kate Wahl, a PhD student… Read More
Assay expands company’s leadership in precision medicine and cell and gene therapy BURLINGTON, NC – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the U.S. Food and Drug Administration (FDA)… Read More
Elmutaz Elrabaa has been promoted to health principal for HDR’s health practice in Canada. In this role, Elrabaa will lead design for the Canadian practice, delivering projects from inception to… Read More
